MayTech Global Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
MayTech Global Investments's BMY Position: Q1 2023 in Review
MayTech Global Investments sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 908 shares — an estimated $65.3K sold.
MayTech Global Investments first reported a position in BMY in Q4 2019 and held it in 12 quarters. The position peaked at $83K in Q4 2019. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.
- MayTech Global Investments reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
- MayTech Global Investments sold 908 Bristol-Myers Squibb shares in Q1 2023, an estimated $65.3K.
- MayTech Global Investments first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 12 quarters.
- MayTech Global Investments's Bristol-Myers Squibb position peaked at $83K in Q4 2019.
- 2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.
Based on MayTech Global Investments's 13F filing for Q1 2023, filed 11 May 2023.